Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Overcoming the Cost Barrier for Thalassemia Innovative Treatments

Angela Vitrano, Rita Barone, Antonino Giangreco, Rosario Di Maggio, Luca Castagna, Gianluca Forni, Emanuele Angelucci, Franco Locatelli, Aurelio Maggio

Blood (2023) 142 (Supplement 1): 5200.

https://doi.org/10.1182/blood-2023-180708

Published: 2023

Journal Articles

The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions

Blood (2018) 132 (Supplement 1): 163.

https://doi.org/10.1182/blood-2018-163

Published: 2018

Journal Articles

The Prognostic Role of Diabetes Mellitus for Cardiac Complications in a Large Cohort of Well Treated Thalassemia Major Patients

Antonella Meloni, PhD, Maria Rita Gamberini, MD, Giuseppe Rossi, MSc, Francesco Sorrentino, MD, Domenico Giuseppe D'Ascola, MD, Anna Spasiano, MD, Aldo Filosa, MD, Liana Cuccia, MD, Nicola Dello Iacono, MD, Gianluca Forni, MD, Vincenzo Caruso, MD, Aurelio Maggio, MD, Lorella Pitrolo, MD, Angelo Peluso, MD, Massimo Midiri, MD, Massimiliano Missere, MD, Maria Giovanna Neri, PhD, Alessia Pepe, MD PhD

Blood (2014) 124 (21): 4043.

https://doi.org/10.1182/blood.V124.21.4043.4043

Published: 2014

Journal Articles

The Impact of Comorbidities on Clinical Outcome of Patients with Myelodysplastic Syndromes: A Real-Life Survey

Blood (2014) 124 (21): 4668.

https://doi.org/10.1182/blood.V124.21.4668.4668

Published: 2014

Journal Articles

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Blood (2014) 124 (21): 1354.

https://doi.org/10.1182/blood.V124.21.1354.1354

Published: 2014

Journal Articles

Cardiac and Liver Magnetic Resonance Characterization of Thalassemia Intermedia Patients: A Comparative Multicenter Study Versus Thalassemia Major Patients

Alessia Pepe, MD, PhD, Brunella Favilli, MSc, Anna Ramazzotti, PhD, Vincenzo Positano, MSc, Caterina Borgna-Pignatti, MD, Marcello Capra, MD, Maria-Eliana Lai, MD, Anna Spasiano, MD, Lorella Pitrolo, MD, Aldo Filosa, MD, Paolo Cianciulli, MD, Antonietta Mascolino, MD, Gaetano Giuffrida, MD, Gianluca Forni, MD, Aurelio Maggio, MD, Massimo Lombardi

Blood (2008) 112 (11): 5421.

https://doi.org/10.1182/blood.V112.11.5421.5421

Published: 2008

Journal Articles

Prevalence, Clinical and Instrumental Correlates of Myocardial Fibrosis and Necrosis by Delayed Contrast Enhancement Cardiovascular Magnetic Resonace in Thalassemia Major Patients

Alessia Pepe, MD, PhD, Brunella Favilli, MSc, Vincenzo Positano, MSc, Marcello Capra, MD, Aurelio Maggio, MD, Carmen Lo Pinto, MD, Anna Spasiano, MD, Gianluca Forni, MD, Aldo Filosa, MD, Caterina Borgna-Pignatti, MD, Paolo Cianciulli, MD, Gaetano Giuffrida, Tommaso Casini, Giorgio Derchi, MD, Massimo Lombardi, MD

Blood (2008) 112 (11): 5424.

https://doi.org/10.1182/blood.V112.11.5424.5424

Published: 2008

Journal Articles

Effect of Iron Chelators on Cardiac Iron Assessed by MR T2* in Thalassemia Major

Renzo Galanello, MD, Antonio Piga, MD, Maria- Eliana Lai, MD, Gianluca Forni, MD, Fabrice Danjou, Filomena Longo, MD, Annalisa Agus, Raffaella Origa

Blood (2008) 112 (11): 3886.

https://doi.org/10.1182/blood.V112.11.3886.3886

Published: 2008

Journal Articles

Manual Erythro-Exchange (MEEX) to Prevent Complications of Sickle Cell Disease in Patients Unresponsive to Hydroxyurea: A Long-Term Follow-up

Gianluca Forni, MD, Manuela Balocco, Laura Terenzani, Paola Carrara

Blood (2008) 112 (11): 4815.

https://doi.org/10.1182/blood.V112.11.4815.4815

Published: 2008

Journal Articles

Multi-Centre Validation of the Cardiovascular Magnetic Resonance Multi Breath-Hold T2* Technique for Myocardial Iron Quantification in Thalassaemia Major.

Mark A. Tanner, MBBS, Taigang He, PhD, Mark A. Westwood, MD, Renzo Galanello, MD, Gildo Matta, MD, Alan R. Cohen, MD, Mark Fogel, MD, Antonio Piga, MD, Gianluca Forni, MD, Charalambos Economides, MD, David N. Firmin, PhD, Pennell J. Dudley, MD

Blood (2005) 106 (11): 3828.

https://doi.org/10.1182/blood.V106.11.3828.3828

Published: 2005

NARROW

Overcoming the Cost Barrier for Thalassemia Innovative Treatments

The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions

The Prognostic Role of Diabetes Mellitus for Cardiac Complications in a Large Cohort of Well Treated Thalassemia Major Patients

The Impact of Comorbidities on Clinical Outcome of Patients with Myelodysplastic Syndromes: A Real-Life Survey

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Cardiac and Liver Magnetic Resonance Characterization of Thalassemia Intermedia Patients: A Comparative Multicenter Study Versus Thalassemia Major Patients

Prevalence, Clinical and Instrumental Correlates of Myocardial Fibrosis and Necrosis by Delayed Contrast Enhancement Cardiovascular Magnetic Resonace in Thalassemia Major Patients

Effect of Iron Chelators on Cardiac Iron Assessed by MR T2* in Thalassemia Major

Manual Erythro-Exchange (MEEX) to Prevent Complications of Sickle Cell Disease in Patients Unresponsive to Hydroxyurea: A Long-Term Follow-up

Multi-Centre Validation of the Cardiovascular Magnetic Resonance Multi Breath-Hold T2* Technique for Myocardial Iron Quantification in Thalassaemia Major.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only